{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:40:01Z","timestamp":1788558001809,"version":"build-2803163510"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Glutamate is an essential excitatory neurotransmitter and an intermediate for energy metabolism. Depending on the tumor site, cancer cells have increased or decreased expression of excitatory amino acid transporter 1 or 2 (EAAT1\/2, <jats:italic>SLC1A3\/2<\/jats:italic>) to regulate glutamate uptake for the benefit of tumor growth. Thus, EAAT1\/2 may be an attractive target for therapeutic intervention in oncology. Genetic variation of EAAT1 has been associated with rare cases of episodic ataxia, but the occurrence and functional contribution of EAAT1 mutants in other diseases, such as cancer, is poorly understood. Here, 105 unique somatic EAAT1 mutations were identified in cancer patients from the Genomic Data Commons dataset. Using EAAT1 crystal structures and <jats:italic>in silico<\/jats:italic> studies, eight mutations were selected based on their close proximity to the orthosteric or allosteric ligand binding sites and the predicted change in ligand binding affinity. <jats:italic>In vitro<\/jats:italic> functional assessment in a live-cell, impedance-based phenotypic assay demonstrated that these mutants differentially affect L-glutamate and L-aspartate transport, as well as the inhibitory potency of an orthosteric (TFB-TBOA) and allosteric (UCPH-101) inhibitor. Moreover, two episodic ataxia-related mutants displayed functional responses that were in line with literature, which confirmed the validity of our assay. Of note, ataxia-related mutant M128R displayed inhibitor-induced functional responses never described before. Finally, molecular dynamics (MD) simulations were performed to gain mechanistic insights into the observed functional effects. Taken together, the results in this work demonstrate 1) the suitability of the label-free phenotypic method to assess functional variation of EAAT1 mutants and 2) the opportunity and challenges of using <jats:italic>in silico<\/jats:italic> techniques to rationalize the <jats:italic>in vitro<\/jats:italic> phenotype of disease-relevant mutants.<\/jats:p>","DOI":"10.3389\/fmolb.2023.1286673","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:16:55Z","timestamp":1700749015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular insights into disease-associated glutamate transporter (EAAT1 \/ SLC1A3) variants using in silico and in vitro approaches"],"prefix":"10.3389","volume":"10","author":[{"given":"Marina","family":"Gorostiola Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert J.","family":"Sijben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dall\u2019 Acqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan P.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Heitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J. P.","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM\u2014a new method for protein modeling and design: applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1523\/JNEUROSCI.3396-12.2013","article-title":"Allosteric modulation of an excitatory amino acid transporter: the subtype-selective inhibitor UCPH-101 exerts sustained inhibition of EAAT1 through an intramonomeric site in the trimerization domain","volume":"33","author":"Abrahamsen","year":"2013","journal-title":"J. Neurosci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/YPG.0b013e328341a307","article-title":"Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome","volume":"21","author":"Adamczyk","year":"2011","journal-title":"Psychiatr. Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"eaba9854","DOI":"10.1126\/sciadv.aba9854","article-title":"Na+-dependent gate dynamics and electrostatic attraction ensure substrate coupling in glutamate transporters","volume":"6","author":"Alleva","year":"2020","journal-title":"Sci. Adv."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11064-021-03252-x","article-title":"Molecular basis of coupled transport and anion conduction in excitatory amino acid transporters","volume":"47","author":"Alleva","year":"2022","journal-title":"Neurochem. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.celrep.2019.06.010","article-title":"Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer","volume":"28","author":"Bacci","year":"2019","journal-title":"Cell Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"330588","DOI":"10.1371\/journal.pone.0033058","article-title":"Position of the third Na + site in the aspartate transporter Glt Ph and the human glutamate transporter, EAAT1","volume":"7","author":"Bastug","year":"2012","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21534","DOI":"10.1038\/s41598-022-25323-x","article-title":"Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors","volume":"12","author":"Bongers","year":"2022","journal-title":"Sci. Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature05455","article-title":"Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter","volume":"445","author":"Boudker","year":"2007","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1145\/1188455.1188544","article-title":"Molecular dynamics---Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006","journal-title":"Proc. 2006 ACM\/IEEE Conf. Supercomput. SC\u201906, November"},{"key":"B12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22064","article-title":"Structure and allosteric inhibition of excitatory amino acid transporter 1","volume":"544","author":"Canul-Tec","year":"2017","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e108341","DOI":"10.15252\/embj.2021108341","article-title":"The ion-coupling mechanism of human excitatory amino acid transporters","volume":"41","author":"Canul\u2010Tec","year":"2022","journal-title":"EMBO J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bpj.2014.05.046","article-title":"The domain interface of the human glutamate transporter EAAT1 mediates chloride permeation","volume":"107","author":"Cater","year":"2014","journal-title":"Biophysical J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-021-03240-9","article-title":"Glutamate transporters have a chloride channel with two hydrophobic gates","volume":"591","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/humu.24089","article-title":"Functional consequences of SLC1A3 mutations associated with episodic ataxia 6","volume":"41","author":"Chivukula","year":"2020","journal-title":"Hum. Mutat."},{"key":"B17","doi-asserted-by":"publisher","first-page":"13855","DOI":"10.1038\/s41598-017-14254-7","article-title":"Genetic variants associated with episodic ataxia in korea","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20255220118","DOI":"10.1073\/pnas.2025520118","article-title":"Linking function to global and local dynamics in an elevator-type transporter","volume":"118","author":"Ciftci","year":"2021","journal-title":"PNAS"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/S41467-023-37503-Y","article-title":"Mutation in glutamate transporter homologue GltTk provides insights into pathologic mechanism of episodic ataxia 6","volume":"14","author":"Colucci","year":"2023","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1002\/ijc.31985","article-title":"Altered function of the glutamate\u2013aspartate transporter GLAST, a potential therapeutic target in glioblastoma","volume":"144","author":"Corbetta","year":"2019","journal-title":"Int. J. Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1021\/acs.jcim.7b00564","article-title":"Relative binding free energy calculations in drug discovery: recent advances and practical considerations","volume":"57","author":"Cournia","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s11064-019-02934-x","article-title":"Amino acid transporters and exchangers from the SLC1A family: structure, mechanism and roles in physiology and cancer","volume":"45","author":"Freidman","year":"2020","journal-title":"Neurochem. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","article-title":"Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours","volume":"20","author":"Garcia-Bermudez","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13420","DOI":"10.1038\/ncomms13420","article-title":"Coupled binding mechanism of three sodium ions and aspartate in the glutamate transporter homologue Glt Tk","volume":"7","author":"Guskov","year":"2016","journal-title":"Nat. Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"key":"B26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1021\/jm8013458","article-title":"Discovery of the first selective inhibitor of excitatory amino acid transporter subtype 1","volume":"52","author":"Jensen","year":"2009","journal-title":"J. Med. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2017-03-735654","article-title":"The NCI Genomic Data Commons as an engine for precision medicine","volume":"130","author":"Jensen","year":"2017","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1038\/s41467-022-32442-6","article-title":"Structural insights into inhibitory mechan-ism of human excitatory amino acid trans-porter EAAT2","volume":"13","author":"Kato","year":"2022","journal-title":"Nat. Commun."},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/bios5020199","article-title":"Application of xCELLigence RTCA biosensor technology for revealing the profile and window of drug responsiveness in real time","volume":"5","author":"Kho","year":"2015","journal-title":"Biosensors"},{"key":"B30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1021\/acschemneuro.7b00308","article-title":"Identification of novel allosteric modulators of glutamate transporter EAAT2","volume":"9","author":"Kortagere","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1014688","DOI":"10.15252\/embj.2019101468","article-title":"Allosteric gate modulation confers K + coupling in glutamate transporters","volume":"38","author":"Kortzak","year":"2019","journal-title":"EMBO J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"13913","DOI":"10.1038\/s41598-017-14176-4","article-title":"Impaired K+ binding to glial glutamate transporter EAAT1 in migraine","volume":"7","author":"Kovermann","year":"2017","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"29847","DOI":"10.1074\/jbc.M202508200","article-title":"A hydrophobic domain in glutamate transporters forms an extracellular helix associated with the permeation pathway for substrates","volume":"277","author":"Leighton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6552","DOI":"10.1021\/acs.chemrev.5b00627","article-title":"Allosteric mechanisms of molecular machines at the membrane: transport by sodium-coupled symporters","volume":"116","author":"Levine","year":"2016","journal-title":"Chem. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fnins.2015.00469","article-title":"Chronic glutamate toxicity in neurodegenerative diseases-What is the evidence?","volume":"9","author":"Lewerenz","year":"2015","journal-title":"Front. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10822-012-9547-0","article-title":"Docking and scoring with ICM: the benchmarking results and strategies for improvement","volume":"26","author":"Neves","year":"2012","journal-title":"J. Computer-Aided Mol. Des."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3389\/fneur.2020.01006","article-title":"Astrocyte glutamate uptake and signaling as novel targets for antiepileptogenic therapy","volume":"11","author":"Peterson","year":"2020","journal-title":"Front. Neurology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"eabf5814","DOI":"10.1126\/sciadv.abf5814","article-title":"Cryo-EM structures of excitatory amino acid transporter 3 visualize coupled substrate, sodium, and proton binding and transport","volume":"7","author":"Qiu","year":"2021","journal-title":"Sci. Adv."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e202213131","DOI":"10.1085\/jgp.202213131","article-title":"The archaeal glutamate transporter homologue GltPh shows heterogeneous substrate binding","volume":"154","author":"Reddy","year":"2022","journal-title":"J. General Physiology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00018-013-1521-z","article-title":"Glutamate transporters in the biology of malignant gliomas","author":"Robert","year":"2014","journal-title":"Cellular and Molecular Life Sciences"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00439-019-02081-x","article-title":"The genetic landscape of the human solute carrier (SLC) transporter superfamily","volume":"138","author":"Schaller","year":"2019","journal-title":"Hum. Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41467-017-02444-w","article-title":"Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2\/SLC1A5","volume":"9","author":"Scopelliti","year":"2018","journal-title":"Nat. Commun."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/S0896-6273(00)80666-2","article-title":"A reentrant loop domain in the glutamate carrier EAAT1 participates in substrate binding and translocation","volume":"21","author":"Seal","year":"1998","journal-title":"Neuron"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1124\/mol.65.4.1008","article-title":"Characterization of novel L-threo-\u03b2-Benzyloxyaspartate derivatives, potent blockers of the glutamate transporters","volume":"65","author":"Shimamoto","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"872335","DOI":"10.3389\/fphar.2022.872335","article-title":"Impedance-based phenotypic readout of transporter function: a case for glutamate transporters","volume":"13","author":"Sijben","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.cmet.2018.07.005","article-title":"A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3","volume":"28","author":"Tajan","year":"2018","journal-title":"Cell Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm0901-1010","article-title":"Glutamate release promotes growth of malignant gliomas","volume":"7","author":"Takano","year":"2001","journal-title":"Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s42003-021-02267-y","article-title":"Kinetic mechanism of Na+-coupled aspartate transport catalyzed by GltTk","volume":"4","author":"Trinco","year":"2021","journal-title":"Commun. Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrn2274","article-title":"Glutamate transporters: confining runaway excitation by shaping synaptic transmission","volume":"8","author":"Tzingounis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.ejmg.2016.06.003","article-title":"Duplications of SLC1A3: associated with ADHD and autism","volume":"59","author":"van Amen-Hellebrekers","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1152\/physrev.00007.2013","article-title":"Mechanisms of glutamate transport","volume":"93","author":"Vandenberg","year":"2013","journal-title":"Physiol. Rev."},{"key":"B53","article-title":"Python 3 reference manual","author":"Van Rossum","year":"2009","journal-title":"CreateSpace"},{"key":"B54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","article-title":"New aspects of amino acid metabolism in cancer","volume":"122","author":"Vettore","year":"2020","journal-title":"Br. J. Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"02506355","DOI":"10.1371\/journal.pone.0250635","article-title":"Observing spontaneous, accelerated substrate binding in molecular dynamics simulations of glutamate transporters","volume":"16","author":"Wang","year":"2021","journal-title":"PLoS ONE"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"Seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J. Open Source Softw."},{"key":"B57","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1093\/brain\/aws255","article-title":"A point mutation associated with episodic ataxia 6 increases glutamate transporter anion currents","volume":"135","author":"Winter","year":"2012","journal-title":"Brain"},{"key":"B58","doi-asserted-by":"publisher","first-page":"e154891","DOI":"10.1172\/JCI154891","article-title":"Ataxia-linked SLC1A3 mutations alter EAAT1 chloride channel activity and glial regulation of CNS function","volume":"132","author":"Wu","year":"2022","journal-title":"J. Clin. Investigation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7555\/JBR.34.20190037","article-title":"Glutamate in cancers: from metabolism to signaling","volume":"34","author":"Yi","year":"2020","journal-title":"J. Biomed. Res."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1286673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T14:16:58Z","timestamp":1700749018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1286673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":59,"alternative-id":["10.3389\/fmolb.2023.1286673"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1286673","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"article-number":"1286673"}}